Table 1 Characteristics of eligible studies included in this meta-analysis
Author name, year | Location | Subjects | Gender (%Female) | Age | RA duration (years) | Follow-up time | Outcomes |
|---|---|---|---|---|---|---|---|
Pinho et al. (2009) [42] | Brazil | Test: 15 Control: 15 | 60.0% | 35–60 | 0.5–10 | 3, 6 months | PI, PD, BOP |
Bıyıkoğlu et al. (2013) [43] | Turkey | Test: 15 Control: 15 | Test: 60.0% Control: 40.0% | Test: 46.6 Control: 46.7 | 6.4 | 1,3,6 months | PI, PD, AL, BOP |
Roman-Torres et al. (2015) [44] | Brazil | Test: 12 Control: 12 | 100% | Test: 45.4 Control: 46.8 | 10.0 | 3Â months | PI, PD, BOP |
Kurgan et al. (2016) [45] | Turkey | Test: 13 Control: 13 | Test: 69.2% Control: 46.2% | Test: 48.5 Control: 41.4 | NA | 3Â months | PI, GI, PD, BOP |
Kurgan et al., (2017) [46] | Turkey | Test: 15 Control: 15 | Test: 60.0% Control: 53.3% | Test: 49.3 Control: 42.1 | NA | 3Â months | PI, GI, PD, AL, BOP |
Zhao et al. (2018) [47] | China | Test: 18 Control: 18 | Test: 77.8% Control: 77.8% | Test: 42.8 Control: 44.8 |  > 6 weeks | 1 month | PI, GI, PD, BOP |
Cosgarea et al. (2019) [40] | Germany | Test: 18 Control: 18 | Test: 77.8% Control: 55.6% | Test: 51.6 Control: 43.6 | 14.9 | 3,6Â months | PD, AL, BOP |